Cidara Therapeutics, Inc.
CDTXDelisted Jan 7, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001610618
Cidara Therapeutics, Inc. was delisted on Jan 7, 2026; its insiders filed their last Form 4 on Jan 9, 2026; 255 institutions reported holding it in 13F filings for Q4 2025, worth $7.36B in total; 3 superinvestors held it, including Maverick Capital and Soros Fund Management.
13F holders, Q2 2022
Institutional positions in Cidara Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 46
- +2 vs. Q1 2022
- Shares held
- 27.2M
- −3.10M (−10.2%) vs. Q1 2022
- Total value
- $13.3M
- −$11.9M (−47.3%) vs. Q1 2022
- New holders
- 8
- 10 more added
- Sold out
- 6
- 12 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CDTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 255 | $7.36B |
| Q3 2025 | 173 | $3.11B |
| Q2 2025 | 109 | $1.26B |
| Q1 2025 | 46 | $205.9M |
| Q4 2024 | 40 | $183.6M |
| Q3 2024 | 27 | $35.6M |
| Q2 2024 | 26 | $16.9M |
| Q1 2024 | 50 | $20.3M |
| Q4 2023 | 51 | $18.4M |
| Q3 2023 | 52 | $22.7M |
| Q2 2023 | 52 | $29.7M |
| Q1 2023 | 54 | $34.4M |
| Q4 2022 | 42 | $20.2M |
| Q3 2022 | 42 | $17.1M |
| Q2 2022 | 46 | $13.3M |
| Q1 2022 | 44 | $25.2M |
| Q4 2021 | 53 | $39.5M |
| Q3 2021 | 50 | $42.1M |
| Q2 2021 | 55 | $40.5M |
| Q1 2021 | 62 | $56.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Cidara Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BVF Inc | 6,861,127 | $3.35M | 0.16% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 4,819,090 | $2.35M | 0.20% | −135,792−2.7% | Reduced |
| Point72 Asset Management, L.P. | 4,200,000 | $2.05M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,461,633 | $1.20M | 0.00% | 00.0% | Unchanged |
| Alethea Capital Management, LLC | 1,677,194 | $819.0K | 1.03% | −262,072−13.5% | Reduced |
| Renaissance Technologies LLC | 1,156,257 | $565.0K | 0.00% | −281,588−19.6% | Reduced |
| 5AM Venture Management, LLC | 1,134,511 | $554.0K | 0.14% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 1,114,837 | $545.0K | 0.00% | +15,538+1.4% | Added |
| Knott David M Jr | 635,254 | $310.0K | 0.14% | +56,100+9.7% | Added |
| Geode Capital Management, LLC | 502,049 | $245.0K | 0.00% | +25,973+5.5% | Added |
| West Family Investments, Inc. | 368,910 | $180.0K | 0.07% | 00.0% | Unchanged |
| US Bancorp | 262,072 | $128.0K | 0.00% | +262,072 | New |
| Bridgeway Capital Management, LLC | 240,000 | $117.0K | 0.00% | −10,000−4.0% | Reduced |
| BlackRock Inc. | 233,188 | $114.0K | 0.00% | −147,391−38.7% | Reduced |
| Artal Group S.A. | 224,675 | $110.0K | 0.01% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 208,443 | $102.0K | 0.05% | −2,288,077−91.7% | Reduced |
| Jeppson Wealth Management, LLC | 181,075 | $88.0K | 0.04% | +37,225+25.9% | Added |
| State Street Corp | 176,237 | $86.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 98,393 | $48.0K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 86,739 | $42.0K | 0.00% | +461+0.5% | Added |
| Goldman Sachs Group Inc | 78,562 | $38.0K | 0.00% | +3,289+4.4% | Added |
| Citadel Advisors LLC | 57,350 | $28.0K | 0.00% | +57,350 | New |
| Millennium Management LLC | 51,654 | $25.0K | 0.00% | +6,501+14.4% | Added |
| Barclays PLC | 44,185 | $22.0K | 0.00% | −3,240−6.8% | Reduced |
| Aveo Capital Partners, LLC | 42,502 | $21.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 40,625 | $20.0K | 0.00% | +40,625 | New |
| Two Sigma Advisers, LP | 38,694 | $19.0K | 0.00% | −115,700−74.9% | Reduced |
| HSBC Holdings PLC | 35,259 | $17.0K | 0.00% | −4,872−12.1% | Reduced |
| Virtu Financial LLC | 25,886 | $13.0K | 0.00% | +25,886 | New |
| Bank of America Corp | 25,157 | $12.0K | 0.00% | −9,077−26.5% | Reduced |
| Advisor Group Holdings, Inc. | 22,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 22,227 | $11.0K | 0.00% | +13,626+158.4% | Added |
| Fisher Asset Management, LLC | 18,800 | $9.00K | 0.00% | +18,800 | New |
| Russell Investments Group, Ltd. | 17,100 | $8.00K | 0.00% | 00.0% | Unchanged |
| Ground Swell Capital, LLC | 11,397 | $6.00K | 0.01% | +11,397 | New |
| Shufro Rose & Co LLC | 10,413 | $5.00K | 0.00% | 00.0% | Unchanged |
| Stratos Wealth Partners, LTD. | 10,489 | $5.00K | 0.00% | 00.0% | Unchanged |
| Pacifica Partners Inc. | 8,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 10,208 | $4.00K | 0.00% | +10,208 | New |
| Morgan Stanley | 1,500 | $1.00K | 0.00% | −1,000−40.0% | Reduced |
| BNP Paribas Arbitrage, SA | 353 | $172 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 800 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11 | $0 | 0.00% | −1,714−99.4% | Reduced |
| JPMorgan Chase & Co | 210 | $0 | 0.00% | +88+72.1% | Added |
| Wells Fargo & Company | 397 | $0 | 0.00% | +44+12.5% | Added |
| Group One Trading, L.P. | 405 | $0 | 0.00% | +405 | New |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −369,099−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −20,532−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −14,522−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −10,900−100.0% | Sold out |
| Bollard Group LLC | 0 | $0 | 0.00% | −7,733−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −636−100.0% | Sold out |